These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 11056198)
1. Region-specific attenuation of a trypsin-like protease in substantia nigra following dopaminergic neurotoxicity by 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine. Usha R; Muralikrishnan D; Thomas B; Ghosh S; Mandal C; Mohanakumar KP Brain Res; 2000 Nov; 882(1-2):191-5. PubMed ID: 11056198 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity. Mohanakumar KP; Muralikrishnan D; Thomas B Brain Res; 2000 May; 864(2):281-90. PubMed ID: 10802035 [TBL] [Abstract][Full Text] [Related]
3. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
4. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum. Thomas B; Mohanakumar KP J Pineal Res; 2004 Jan; 36(1):25-32. PubMed ID: 14675127 [TBL] [Abstract][Full Text] [Related]
6. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. Viswanath V; Wu Y; Boonplueang R; Chen S; Stevenson FF; Yantiri F; Yang L; Beal MF; Andersen JK J Neurosci; 2001 Dec; 21(24):9519-28. PubMed ID: 11739563 [TBL] [Abstract][Full Text] [Related]
7. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway. Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692 [TBL] [Abstract][Full Text] [Related]
8. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Sirinathsinghji DJ; Whittington PE; Audsley AR Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361 [TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722 [TBL] [Abstract][Full Text] [Related]
10. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Holmer HK; Keyghobadi M; Moore C; Meshul CK Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485 [TBL] [Abstract][Full Text] [Related]
11. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey. Irwin I; DeLanney LE; Forno LS; Finnegan KT; Di Monte DA; Langston JW Brain Res; 1990 Oct; 531(1-2):242-52. PubMed ID: 1981162 [TBL] [Abstract][Full Text] [Related]
12. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. Saporito MS; Brown EM; Miller MS; Carswell S J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541 [TBL] [Abstract][Full Text] [Related]
13. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333 [TBL] [Abstract][Full Text] [Related]
14. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset. Rose S; Nomoto M; Jackson EA; Gibb WR; Jenner P; Marsden CD Eur J Pharmacol; 1990 May; 181(1-2):97-103. PubMed ID: 2117541 [TBL] [Abstract][Full Text] [Related]
15. In vivo electrochemical studies of dopamine overflow and clearance in the striatum of normal and MPTP-treated rhesus monkeys. Gerhardt GA; Cass WA; Hudson J; Henson M; Zhang Z; Ovadia A; Hoffer BJ; Gash DM J Neurochem; 1996 Feb; 66(2):579-88. PubMed ID: 8592127 [TBL] [Abstract][Full Text] [Related]
16. 1-Methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine (MCTP): an alicyclic MPTP-like neurotoxin. Youngster SK; Saari WS; Heikkila RE Neurosci Lett; 1987 Aug; 79(1-2):151-6. PubMed ID: 3499585 [TBL] [Abstract][Full Text] [Related]
17. Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Mitra N; Mohanakumar KP; Ganguly DK Brain Res Bull; 1992 Mar; 28(3):355-64. PubMed ID: 1350496 [TBL] [Abstract][Full Text] [Related]
18. Zinc potentiates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced dopamine depletion in caudate nucleus of mice brain. Hussain S; Ali SF Neurosci Lett; 2002 Dec; 335(1):25-8. PubMed ID: 12457734 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. Muralikrishnan D; Mohanakumar KP FASEB J; 1998 Jul; 12(10):905-12. PubMed ID: 9657530 [TBL] [Abstract][Full Text] [Related]
20. Differential release of acetylcholinesterase in vivo, from the guinea pig substantia nigra compared to the caudate putamen following dopamine depletion. Dally JJ; Temlett JA; Greenfield SA Neuropharmacology; 1996 May; 35(5):579-87. PubMed ID: 8887965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]